Wednesday, 18 September 2019

Top 20: Malaysia - Crosses $1B Mark

09 July 2014 | Analysis | By BioSpectrum Bureau


Singapore: Malaysia has been strengthening its base during the few years attracting significant investments and collaborations. Some of the key developments include:

Malaysia-based biotech park Bio-XCell and Singapore's biotech association, BioSingapore, collaborated to spearhead biotechnology development by promoting cross-border alliances.

Malaysian companies entered into several partnerships during BioMalaysia 2013, injecting investment of around $110 million.

Malaysia's Medical Device Authority issued guidance on good distribution practices.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls